Social Support and Self-efficacy for Abstinence: is Peer Identification an Issue?
Overview
Affiliations
This study investigated levels of abstinence social support and abstinence self-efficacy in relation to characteristics among recovering substance abusers (57 men, 43 women) residing in Oxford Houses. Significant relationships between treatment and sociodemographic variables were observed on measures of abstinence social support and abstinence self-efficacy. Residence time in an Oxford House and 12-step participation were related to increased levels of abstinence social support and abstinence self-efficacy. However, residents who reported that their veteran status or prior incarceration experiences were issues they perceived as making identification with other recovering peers difficult reported lower levels of abstinence social support. In addition, residents who reported having at least one identification issue (57%) and residents who reported being a parent (73%) also reported lower levels of abstinence self-efficacy. Results of this study have important treatment implications for our understanding of social support and self-efficacy within ongoing recovery.
The Importance of Social Support in Recovery Populations: Toward a Multilevel Understanding.
Islam M, Guerrero M, Nguyen R, Porcaro A, Cummings C, Stevens E Alcohol Treat Q. 2023; 41(2):222-236.
PMID: 37312815 PMC: 10259869. DOI: 10.1080/07347324.2023.2181119.
Complex Contexts within Oxford Houses: Psychiatrically Comorbid Social Networks.
Bobak T, Majer J, Jason L Alcohol Treat Q. 2023; 41(2):237-249.
PMID: 37274149 PMC: 10237632. DOI: 10.1080/07347324.2023.2181120.
Bertz J, Smith K, Panlilio L, Stull S, Reamer D, Murville M Drug Alcohol Depend Rep. 2023; 1:100011.
PMID: 36843907 PMC: 9948824. DOI: 10.1016/j.dadr.2021.100011.
The Involvement in Alcoholics Anonymous Scale - Short Form: Factor Structure & Validation.
Beasley C, LaBelle O, Vest N, Olson B, Skinner M, Ferrari J Subst Use Misuse. 2022; 58(1):119-128.
PMID: 36474456 PMC: 9951623. DOI: 10.1080/10826084.2022.2149245.
Jason L, Guerrero M, Salomon-Amend M, Light J, Stoolmiller M Drugs (Abingdon Engl). 2021; 28(5):504-510.
PMID: 34720462 PMC: 8549579. DOI: 10.1080/09687637.2020.1856787.